stockrowInflaRx N.V. (IFRX) vs ProQR Therapeutics N.V. (PRQR)
- InflaRx N.V. IFRX 1.31 −3.68%
- ProQR Therapeutics N.V. PRQR 1.35 +1.50%
InflaRx N.V. and ProQR Therapeutics N.V. are both Biotechnology companies. InflaRx N.V. and ProQR Therapeutics N.V. are of similar size ($192.3M and $190.5M). ProQR Therapeutics N.V. grew revenue faster over the last twelve months: 19.7% against −83.4%. InflaRx N.V. has the higher net margin (0.00% vs −228.7%) and the lower return on invested capital (−87.3% vs 0.00%). Across the 17 metrics below, InflaRx N.V. leads on 12 and ProQR Therapeutics N.V. on 5.
Valuation
Profitability
| Metric | IFRX | PRQR | Biotechnology median |
|---|---|---|---|
| Gross margin | (26,762.42%) | 100.00% | 68.51% |
| Operating margin | 0.00% | (233.33%) | 0.00% |
| Net margin | 0.00% | (228.71%) | 0.00% |
| Free cash flow margin | 0.00% | (267.36%) | 0.00% |
| Return on equity | (30.98%) | (58.29%) | (51.96%) |
| Return on assets | (25.90%) | (31.53%) | (46.06%) |
| Return on invested capital | (87.31%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack